Incidence of preclinical manifestations of mantle cell lymphoma and mantle cell lymphoma in situ in reactive lymphoid tissues

Modern Pathology

Volumn 25, Issue 12, 2012, Pages 1629-1636

  Adam, Patrick ^a   Schiefer, Ana Iris ^b   Prill, Sophie ^a   Henopp, Tobias ^a   Quintanilla Martínez, Leticia ^a   Bösmüller, Hans Christian ^c   Chott, Andreas ^d   Fend, Falko ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Krankenhaus der Barmherzigen Schwestern Linz   (Austria)

^d WILHELMINEN HOSPITAL   (Austria)

Author keywords

mantle cell lymphoma 'in situ; preclinical manifestations of mantle cell lymphoma; reactive lymph nodes

Indexed keywords

CYCLIN D1;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; INCIDENCE; LYMPH NODE; LYMPHOCYTIC INFILTRATION; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; MANTLE CELL LYMPHOMA IN SITU; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUSTRIA; B-LYMPHOCYTES; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 14; CLONE CELLS; COMORBIDITY; CYCLIN D1; DISEASE PROGRESSION; FEMALE; GIANT LYMPH NODE HYPERPLASIA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPH NODES; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84870484304     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2012.117     Document Type: Article

References (19)

1. Swerdlow SH, Campo E, Seto M, Mu? ller-Hermelink HK. Mantle cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds). World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues 4th edn, Vol., IARC Press: Lyon, 2008, pp 229-232.
2. Dolken G, Illerhaus G, Hirt C, Mertelsmann R. BCL-2/ JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases. J Clin Oncol 1996;14:1333-1344.
3. Schuler F, Hirt C, Dolken G. Chromosomal translocation t(14;18) in healthy individuals. Semin Cancer Biol 2003;13:203-209. (Pubitemid 36577692)
4. Hirt C, Schuler F, Dolken L, Schmidt CA, Dolken G. Low prevalence of circulating t(11;14)(q13;q32)-positive cells in the peripheral blood of healthy individuals as detected by real-time quantitative PCR. Blood 2004;104:904-905. (Pubitemid 38970591)
5. Marculescu R, Vanura K, Montpellier B, et al. Recombinase, chromosomal translocations and lymphoid neoplasia: targeting mistakes and repair failures. DNA Repair 2006;5:1246-1258. (Pubitemid 44291609)
6. Lecluse Y, Lebailly P, Roulland S, et al. t(11;14)- positive clones can persist over a long period of time in the peripheral blood of healthy individuals. Leukemia 2009;23:1190-1193.
7. Aqel N, Barker F, Patel K, Naresh KN. In-situ mantle cell lymphoma - a report of two cases. Histopathology 2008;52:256-260.
8. Carvajal-Cuenca A, Sua LF, Silva NM, et al. In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior. Haematologica 2011.
9. Richard P, Vassallo J, Valmary S, et al. 'In situ-like' mantle cell lymphoma: a report of two cases. J Clin Pathol 2006;59:995-996. (Pubitemid 44422859)
10. Henopp T, Quintanilla-Martinez L, Fend F, Adam P. Prevalence of follicular lymphoma in situ in consecutively analysed reactive lymph nodes. Histopathology 2011;59:139-142.
11. Trainor KJ, Brisco MJ, Wan JH, et al. Gene rearrangement in B- and T-lymphoproliferative disease detected by the polymerase chain reaction. Blood 1991;78: 192-196.
12. Geissmann F, Ruskone-Fourmestraux A, Hermine O, et al. Homing receptor alpha4beta7 integrin expression predicts digestive tract involvement in mantle cell lymphoma. Am J Pathol 1998;153:1701-1705. (Pubitemid 28550657)
13. Nakamura S, Matsumoto T, Takeshita M, et al. A clinicopathologic study of primary small intestine lymphoma: prognostic significance of mucosa-associated lymphoid tissue-derived lymphoma. Cancer 2000;88:286-294. (Pubitemid 30051811)
14. Neto AG, Oroszi G, Protiva P, et al. Colonic in situ mantle cell lymphoma. Ann Diagn Pathol; advance online publication, 16 August 2011 (in press). 15 Dantoc MM, Eslick GD, Adams SS, Kalantar JS. Gastrointestinal mantle cell lymphoma - a tale of two endoscopies. J Gastrointest Cancer 2011.
15. Ek S, Dictor M, Jerkeman M, Jirstrom K, Borrebaeck CA. Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma. Blood 2008;111:800-805.
16. Mozos A, Royo C, Hartmann E, et al. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica 2009;94:1555-1562.
17. Dictor M, Ek S, Sundberg M, et al. Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma. Haematologica 2009;94: 1563-1568.
18. Fernandez V, Salamero O, Espinet B, et al. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res 2010;70: 1408-1418.
19. Fend F, Cabecadas J, Gaulard P, et al. Early lesions in lymphoid neoplasia. J Hematopathol; advance online publication, 4 May 2012; doi:10.1007/s12308-012- 0148-6; e-pub ahead of print.